Credit Suisse Starts PDL BioPharma (PDLI) at Neutral
Tweet Send to a FriendGet Alerts PDLI Hot Sheet
Price: $8.37 +0.24%
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade PDLI Now!
Credit Suisse initiates coverage on PDL BioPharma (NASDAQ: PDLI) with a Neutral. PT $6.50.
For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.
Shares of PDL BioPharma closed at $7.83 yesterday, with a 52 week range of $5.76-$8.43.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on PDL BioPharma click here. For more ratings news on PDL BioPharma click here.
Shares of PDL BioPharma closed at $7.83 yesterday, with a 52 week range of $5.76-$8.43.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Topeka Capital Starts Cavium Networks (CAVM) at Hold
- Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
